Vanguard Health Care ETF

    $VHT · Vanguard · tracks MSCI US IMI Health Care 25/50 Index · since 2004

    Dividend yield

    1.56%

    Expense ratio

    0.10%

    Assets

    $19.8B

    Weighted P/E

    21.6x

    About VHT

    Broader than XLV — includes large-, mid-, and small-cap U.S. healthcare stocks across pharma, biotech, devices, services, and life sciences tools. Vanguard's low fee makes it a core healthcare allocation.

    Top holdings

    Eli Lilly & Co.$LLYJohnson & Johnson$JNJUnitedHealth Group$UNHAbbVie Inc.$ABBVMerck & Co.$MRKThermo Fisher Scientific$TMOAbbott Laboratories$ABTIntuitive Surgical$ISRGDanaher Corp.$DHRPfizer Inc.$PFE

    Sector exposure

    • Pharmaceuticals32.6%
    • Healthcare Equipment22.4%
    • Biotechnology16.8%
    • Healthcare Providers14.2%
    • Life Sciences Tools10.6%
    • Other3.4%

    How StockWorthy analyses VHT

    ETFs hold companies rather than generating cash flow themselves, so VHT is assessed on cost, income and the valuation of what it owns: the expense ratio, the current yield against its own 1.48% long-run average, and a holdings-weighted P/E and growth rate built from the underlying positions. Figures are educational and not investment advice.

    Sign in to see live pricing, yield history and the full holdings breakdown, or browse all ETFs.